Plasma Letrozole Concentrations in Postmenopausal Women With Breast Cancer Are Associated With CYP2A6 Genetic Variants, Body Mass Index, and Age

The associations between plasma letrozole concentrations and CYP2A6 and CYP3A5 genetic variants were tested in the Exemestane and Letrozole Pharmacogenomics (ELPH) trial. ELPH is a multicenter, open-label prospective clinical trial in women randomly assigned (n ≈ 250 in each arm) to receive 2 years...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Desta, Z, Kreutz, Y, Nguyen, AT, Li, L, Skaar, T, Kamdem, LK, Henry, NL, Hayes, DF, Storniolo, AM, Stearns, V, Hoffmann, E, Tyndale, RF, Flockhart, DA
Médium: Artigo
Jazyk:Inglês
Vydáno: 2011
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3667657/
https://ncbi.nlm.nih.gov/pubmed/21975350
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/clpt.2011.174
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky